You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice
|
---|---|
Published in |
BMC Cancer, January 2014
|
DOI | 10.1186/1471-2407-14-30 |
Pubmed ID | |
Authors |
Victoria Hillerdal, Mohanraj Ramachandran, Justyna Leja, Magnus Essand |
Abstract |
Adoptive transfer of T cells genetically engineered with a chimeric antigen receptor (CAR) has successfully been used to treat both chronic and acute lymphocytic leukemia as well as other hematological cancers. Experimental therapy with CAR-engineered T cells has also shown promising results on solid tumors. The prostate stem cell antigen (PSCA) is a protein expressed on the surface of prostate epithelial cells as well as in primary and metastatic prostate cancer cells and therefore a promising target for immunotherapy of prostate cancer. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 3% |
Switzerland | 1 | 1% |
Portugal | 1 | 1% |
United Kingdom | 1 | 1% |
Australia | 1 | 1% |
Unknown | 91 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 20 | 20% |
Student > Ph. D. Student | 15 | 15% |
Student > Master | 13 | 13% |
Student > Bachelor | 11 | 11% |
Student > Doctoral Student | 7 | 7% |
Other | 10 | 10% |
Unknown | 22 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 23 | 23% |
Medicine and Dentistry | 18 | 18% |
Immunology and Microbiology | 12 | 12% |
Biochemistry, Genetics and Molecular Biology | 8 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
Other | 7 | 7% |
Unknown | 26 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 December 2020.
All research outputs
#3,178,908
of 24,080,653 outputs
Outputs from BMC Cancer
#704
of 8,553 outputs
Outputs of similar age
#37,793
of 313,816 outputs
Outputs of similar age from BMC Cancer
#12
of 116 outputs
Altmetric has tracked 24,080,653 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,553 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 313,816 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 116 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.